Poulin i willey i anastopoulo announces a class action lawsuit has been filed against lifecore biomedical, inc. (lfcr)

Poulin willey anastopoulo llc announces that a class action has been filed in the united states district court for the district of minnesota on behalf of all persons and entities that purchased or otherwise acquired (or owned) the securities of lifecore biomedical, inc. (“lfcr” or the “company”) (nasdaq:lfcr) between october 7, 2020, and march 19, 2024, both dates inclusive (the “class period”). the company, together with its subsidiaries, operates as an integrated contract development and manufacturing organization in the u.s. and internationally, purportedly designing, developing, manufacturing, and selling differentiated products for biomaterials markets, and license technology applications to partners. poulin willey anastopoulo llc announces that a class action has been filed in the united states district court for the district of minnesota on behalf of all persons and entities that purchased or otherwise acquired (or owned) the securities of lifecore biomedical, inc. (“lfcr” or the “company”) (nasdaq:lfcr) between october 7, 2020, and march 19, 2024, both dates inclusive (the “class period”). the company, together with its subsidiaries, operates as an integrated contract development and manufacturing organization in the u.s. and internationally, purportedly designing, developing, manufacturing, and selling differentiated products for biomaterials markets, and license technology applications to partners.
LFCR Ratings Summary
LFCR Quant Ranking